M. Metintas (Eskisehir, Turkey), R. Mukherjee (Wolverhampton, United Kingdom)
Mesothelioma in England – results from the national lung cancer audit 2005-2007
P. Beckett, I. Woolhouse, R. Stanley, M. Peake (London, Leeds, United Kingdom)
|   |
Postal questionnaire survey of public awareness of mesothelioma risk
I. Jarrold, J. Morrell, N. Eiser (London, United Kingdom)
| |
Audit of pain control in patients with mesothelioma
L. Jones, S. Bolton, A. M. Seymour (Leeds, Dewsbury, Wakefield, United Kingdom)
| |
A spray catheter technique of lidocaine for controlling pain after talc poudrage in patients with malignant pleural effusion
A. Navasakulpong, A. Jatakanon, A. Wattanathum (Rachathewi, Thailand)
| |
A prospective study on etiology of haemorrhagic pleural effusion
S. Kant, R. Singh, R. A. S. Kushwaha (Lucknow, India)
| |
Initial management of pleural effusions: an audit of our practice – could we do better to improve patient care and reduce length of stay?
M. McDonnell, M. Fitzgibbon, F. Hunt, C. Palmer, A. Guhan (Middlesbrough, United Kingdom)
| |
Videothoracoscopy in the treatment of malignant pleural effusions
O. Chayka, V. Klimenko, M. Gelfond, A. Arseniev, A. Sherbakov, V. Semiglazov (Saint-Petersburg, Russian Federation)
| |
Diagnostic pleuroscopy and pleuroscopic talc pleurodesis in malignant pleural effusions – a study on efficacy and safety
B. N. B. M. Prasad, S. P. Rai, D. Bhattacharyya, V. Dutta (Pune, New Delhi, India)
| |
Small bored catheter thoracostomy: smart choice in pleural effusions
K. Navari, T. Eftekhaari, F. Navari, N. Ziaee (Bandar Abbas, Islamic Republic Of Iran)
| |
Pleurodesis by using tranexamic acid via tube drainage
M. Shahat Badawy, K. Eisa (Sohag, Egypt)
| |
Malignant pleural effusion related empyema — etiology, pathogen, and management
C. J. Huang, Y. J. Hung (Taipei, Taiwan)
| |
The inhibitory effect of PI3k inhibitor and MEK inhibitor on malignant pleural mesothelioma cell growth
S. Miyoshi, H. Hamada, S. Shiraishi, A. Fujiwara, N. Hamaguchi, C. Sato, R. Ito, J. Higaki (Toon, Japan)
| |
Comparison between treatment with IL2, and IL2 in combination with chemotherapy in malignant pleural mesothelioma
E. Roca, V. Pinelli, G. P. Marchetti, M. Trigiani, G. F. Tassi (Brescia, Cremona, Italy)
| |
A case of mesothelioma which had aggressive course with unusual distant organ metastases
E. Akpinar, H. Haliloglu, O. Ataoglu, M. Gülhan (Ankara, Turkey)
| |
Polychemotherapy experience in pleural mesothelioma with or without pemetrexed
E. Roca, V. Pinelli, A. Caprioli, A. M. Nava, G. F. Tassi (Brescia, Italy)
| |
Five-year survival after treatment of a pulmonary artery angiosarcoma
H. Le Floch, A. Bonnichon, F. Rivière, P. Saint Blancard, R. Jancovici, F. Vaylet, J. Margery (Clamart, France)
| |
Complete metabolic remission of an irresectable mediastinal solitary fibrous tumor with concurrent chemo-radiation
L. Vanfleteren, H. Peulen, D. Creytens, N. Smulders, I. Utama, D. De Ruysscher, G. Ten Velde (Maastricht, Roermond, Netherlands)
| |
Mediastinal masses – case series
R. Monteiro, T. M. Alfaro, R. Garcia, J. Velez, A. Carvalho, R. Santos, C. Robalo Cordeiro, N. Costa (Coimbra, Portugal)
| |
Clinicopathologic features, histologic and immunohistochemical characteristics, and clinical outcome of patients with cardiac myofibroblastic tumors
M. Ribo, A. De Luna (Quezon City, Philippines)
| |
Primary fibrosarcoma of the diaphragm with plueral effusion
H. Zhang, Z. Wang, J. Xu, H. Wang (Hangzhou, China)
| |